A

Aclaris Therapeutics
D

ACRS

2.58500
USD
0.00
(0.00%)
Market Closed
Volume
20,586
EPS
-1
Div Yield
-
P/E
-5
Market Cap
276,643,430
OverviewSignalsIdeasNews
Related Instruments
    A
    ADCT
    -0.06000
    (-3.40%)
    1.70500 USD
    A
    AGEN
    -0.15000
    (-3.94%)
    3.66000 USD
    A
    ALXO
    0.15000
    (9.15%)
    1.79000 USD
    AMGN
    AMGN
    -1.26
    (-0.46%)
    273.59 USD
    A
    ASMB
    0.282
    (1.97%)
    14.610 USD
    B
    BCRX
    0.01500
    (0.20%)
    7.62000 USD
    BIIB
    BIIB
    1.810
    (1.28%)
    142.750 USD
    B
    BPMC
    -0.940
    (-0.84%)
    111.190 USD
    C
    CRSP
    2.740
    (6.61%)
    44.200 USD
    GILD
    GILD
    0.070
    (0.08%)
    93.020 USD
    I
    INCY
    -1.050
    (-1.43%)
    72.420 USD
    MRK
    MRK
    -0.560
    (-0.58%)
    95.670 USD
    N
    NKTR
    0.02170
    (2.39%)
    0.93110 USD
    NVS
    NVS
    -1.600
    (-1.60%)
    98.180 USD
    P
    PTCT
    -0.150
    (-0.33%)
    45.100 USD
    More
News

Title: Aclaris Therapeutics

Sector: Healthcare
Industry: Diagnostics & Research
Aclaris Therapeutics Inc is a clinical-stage biopharmaceutical company that operates in the United States. It focuses on developing novel drug candidates for immuno-inflammatory diseases. The company operates in two segments: therapeutics and contract research. The therapeutics segment is focused on identifying and developing inventive therapies to address unmet needs for immuno-inflammatory diseases. The contract research segment earns revenue from the provision of laboratory services. The majority of its revenue comes from the contract research segment, which provides laboratory services. Its drug candidates under development are Zunsemetinib, which is an Oral MK2 Inhibitor; ATI-2138 is an ITJ Inhibitor; andATI-1777.
Trading. Social. Simple.
FacebookTwitterYoutube
Company
Contact usAbout usTerms Of UsePrivacy PolicyCookies PolicyDisclaimerHelp Center
Social Network
The NetworkSignals NetworkIdeas NetworkBest Traders
Products
Risk CalculatorPip CalculatorAdvance Chart
Markets
Exchange RatesCommodities RatesCryptocurrencies RatesIndices RatesUS Stocks Rates
Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.